Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead

Hamed Ekhtiari, Hosna Tavakoli, Giovanni Addolorato, Chris Baeken, Antonello Bonci, Salvatore Campanella, Luis Castelo-Branco, Gaëlle Challet-Bouju, Vincent P Clark, Eric Claus, Pinhas N Dannon, Alessandra Del Felice, Tess den Uyl, Marco Diana, Massimo di Giannantonio, John R Fedota, Paul Fitzgerald, Luigi Gallimberti, Marie Grall-Bronnec, Sarah C Herremans, Martin J Herrmann, Asif Jamil, Eman Khedr, Christos Kouimtsidis, Karolina Kozak, Evgeny Krupitsky, Claus Lamm, William V Lechner, Graziella Madeo, Nastaran Malmir, Giovanni Martinotti, William M McDonald, Chiara Montemitro, Ester M Nakamura-Palacios, Mohammad Nasehi, Xavier Noël, Masoud Nosratabadi, Martin Paulus, Mauro Pettorruso, Basant Pradhan, Samir K Praharaj, Haley Rafferty, Gregory Sahlem, Betty Jo Salmeron, Anne Sauvaget, Renée S Schluter, Carmen Sergiou, Alireza Shahbabaie, Christine Sheffer, Primavera A Spagnolo, Vaughn R Steele, Ti-Fei Yuan, Josanne D M van Dongen, Vincent Van Waes, Ganesan Venkatasubramanian, Antonio Verdejo-García, Ilse Verveer, Justine W Welsh, Michael J Wesley, Katie Witkiewitz, Fatemeh Yavari, Mohammad-Reza Zarrindast, Laurie Zawertailo, Xiaochu Zhang, Yoon-Hee Cha, Tony P George, Flavio Frohlich, Anna E Goudriaan, Shirley Fecteau, Stacey B Daughters, Elliot A Stein, Felipe Fregni, Michael A Nitsche, Abraham Zangen, Marom Bikson, Colleen A Hanlon, Hamed Ekhtiari, Hosna Tavakoli, Giovanni Addolorato, Chris Baeken, Antonello Bonci, Salvatore Campanella, Luis Castelo-Branco, Gaëlle Challet-Bouju, Vincent P Clark, Eric Claus, Pinhas N Dannon, Alessandra Del Felice, Tess den Uyl, Marco Diana, Massimo di Giannantonio, John R Fedota, Paul Fitzgerald, Luigi Gallimberti, Marie Grall-Bronnec, Sarah C Herremans, Martin J Herrmann, Asif Jamil, Eman Khedr, Christos Kouimtsidis, Karolina Kozak, Evgeny Krupitsky, Claus Lamm, William V Lechner, Graziella Madeo, Nastaran Malmir, Giovanni Martinotti, William M McDonald, Chiara Montemitro, Ester M Nakamura-Palacios, Mohammad Nasehi, Xavier Noël, Masoud Nosratabadi, Martin Paulus, Mauro Pettorruso, Basant Pradhan, Samir K Praharaj, Haley Rafferty, Gregory Sahlem, Betty Jo Salmeron, Anne Sauvaget, Renée S Schluter, Carmen Sergiou, Alireza Shahbabaie, Christine Sheffer, Primavera A Spagnolo, Vaughn R Steele, Ti-Fei Yuan, Josanne D M van Dongen, Vincent Van Waes, Ganesan Venkatasubramanian, Antonio Verdejo-García, Ilse Verveer, Justine W Welsh, Michael J Wesley, Katie Witkiewitz, Fatemeh Yavari, Mohammad-Reza Zarrindast, Laurie Zawertailo, Xiaochu Zhang, Yoon-Hee Cha, Tony P George, Flavio Frohlich, Anna E Goudriaan, Shirley Fecteau, Stacey B Daughters, Elliot A Stein, Felipe Fregni, Michael A Nitsche, Abraham Zangen, Marom Bikson, Colleen A Hanlon

Abstract

There is growing interest in non-invasive brain stimulation (NIBS) as a novel treatment option for substance-use disorders (SUDs). Recent momentum stems from a foundation of preclinical neuroscience demonstrating links between neural circuits and drug consuming behavior, as well as recent FDA-approval of NIBS treatments for mental health disorders that share overlapping pathology with SUDs. As with any emerging field, enthusiasm must be tempered by reason; lessons learned from the past should be prudently applied to future therapies. Here, an international ensemble of experts provides an overview of the state of transcranial-electrical (tES) and transcranial-magnetic (TMS) stimulation applied in SUDs. This consensus paper provides a systematic literature review on published data - emphasizing the heterogeneity of methods and outcome measures while suggesting strategies to help bridge knowledge gaps. The goal of this effort is to provide the community with guidelines for best practices in tES/TMS SUD research. We hope this will accelerate the speed at which the community translates basic neuroscience into advanced neuromodulation tools for clinical practice in addiction medicine.

Keywords: Addiction; NIBS; Non-invasive brain stimulation; Psychiatry; Substance use disorder; Transcranial electrical stimulation; Transcranial magnetic stimulation; rTMS; tDCS; tES.

Conflict of interest statement

Declaration of Competing Interest

Flavio Frohlich is the founder, majority owner, and Chief Scientific Officer of Pulvinar Neuro LLC. Michael Nitsche is a member of the Scientific Advisory Board of Neuroelectrics. Colleen A. Hanlon has served as a consultant for Brain Research and Development Services (Brainsway). Other authors reported no conflict of interest.

Copyright © 2019 Elsevier Ltd. All rights reserved.

Figures

Fig. 1.
Fig. 1.
Three major non-invasive brain stimulation technologies. Repeated transcranial magnetic stimulation (rTMS) in its both conventional and deep forms and also transcranial direct current stimulation (tDCS) have been used frequently in addiction medicine trials. Other forms of the transcranial electrical stimulation (tES), like transcranial alternating current stimulation (tACS) have not been used in published addiction medicine trials (till June 1, 2018).
Fig. 2.
Fig. 2.
PRISMA flow diagrams for published rTMS (panel A) and tDCS (panel B) trials in drug addiction.
Fig. 3.
Fig. 3.
Contribution by country of tDCS/rTMS studies (n = 84) for addiction medicine, color coded for type of stimulation (Y axis represents number of studies).
Fig. 4.
Fig. 4.
The number of tDCS/rTMS studies from each country color coded according to substance type (n = 84 but 3 studies included 2 drugs).
Fig. 5.
Fig. 5.
Brain targets for TMS/tDCS trials in addiction medicine. Right panel: Seventy seven out of 84 published TMS/tDCS studies (till June 1, 2018) selected DLPFC as the target of stimulation including right, left, or bilateral DLPFC. Each trial with bilateral stimulation counted in both right and left categories. In 13 tDCS studies, one of the electrodes was placed on right supraorbital area (counted as frontal pole). All deep TMS (dTMS) studies are bilateral with both high and low frequency (HF and LF) TMS. Left panel: The number of TMS and tDCS studies in each target. DLPFC, dorsolateral prefrontal cortex; ACC, anterior cingulate cortex; FP, frontal pole; SFG, superior frontal gyrus; IFG, inferior frontal gyrus; TP, temporoparietal and M1, motor cortex.
Fig. 6.
Fig. 6.
Phases of recovery during which tDCS/rTMS was administered, divided amongst SUD groups.
Fig. 7.
Fig. 7.
Major groups of outcome measures in 84 tDCS/rTMS studies.

Source: PubMed

3
Subskrybuj